#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypersomnia Systemic mastocytosis Mantle cell lymphoma refractory Plasma cell myeloma Non-Hodgkin's lymphoma refractory Conjunctivitis allergic Pituitary-dependent Cushing's syndrome Frostbite Cutaneous T-cell lymphoma stage I Cryoglobulinaemia Juvenile psoriatic arthritis Pulmonary sarcoidosis Oesophageal adenocarcinoma stage III Arterial tortuosity syndrome Indolent systemic mastocytosis More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Arterial tortuosity syndrome – Trials in Disease Rhabdoid tumour – Diagnostics Crigler-Najjar syndrome – Basic Information Synovial sarcoma metastatic Sjogren’s syndrome – Diagnostics Pulmonary sarcoidosis – Treatment Mantle cell lymphoma stage II – Basic Information SAPHO syndrome – Basic Information Mucopolysaccharidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Artemisia Vulgaris (312) Sodium Cromoglicate Brivaracetam Interleukin-1 Omp10 Mva-209-Fsp-B3 Protamine Sulfate Xenon Prasterone Salbutamol Sulfate Ph. Eur. Trifluridine Degarelix Acetate Valproate Semisodium Glatiramer Acetate Quinapril Hydrochloride Azd0901 Abc-23A-116 Desloratadine Colecalciferol Triptorelin Pamoate More therapies…

    Learn about Your Condition

    Ophthalmoplegia Influenza Addison's disease Pyoderma gangrenosum Vascular graft thrombosis Chronic coronary syndrome Primary amyloidosis Pneumonia Renal cancer metastatic Eructation Critical illness Fibrosarcoma metastatic Anal fissure Osteogenesis imperfecta Lung cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Saint Antoine

Hopital Saint Antoine

184 Rue Du Faubourg Saint Antoine, Paris, 75571, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Emavusertib
    France Germany Spain

  • Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Elranatamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Czechia Finland France Germany +7

  • Study on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Cabotegravir Sodium
    • Lenacapavir
    • Cabotegravir
    France

  • Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate Ph. Eur.
    • Isatuximab
    • Bortezomib
    Czechia Denmark France Germany Greece Italy +5

  • Study on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Regorafenib
    France

  • Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Busulfan
    • Fludarabine Phosphate
    France

  • Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment

    Not recruiting

    3 1 1 1
    France Germany Italy Poland Spain

  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Study on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Giant cell arteritis
    Investigated Drugs:
    • Tocilizumab
    France

  • Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Folinic Acid
    • Docetaxel
    • Durvalumab
    Belgium Denmark France Germany Hungary The Netherlands +2
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!